MyAverix Finance
TWO · Healthcare
Eusol Biotech Co.,Ltd. (6652)
Biotechnology
Eusol Biotech Co.,Ltd. (6652) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6652
Eusol Biotech Co.,Ltd. (6652) — FAQ
What is 6652's P/E ratio?
The price-to-earnings (P/E) ratio for Eusol Biotech Co.,Ltd. (6652) is 25.00 (data as of 2026-05-23).
Does Eusol Biotech Co.,Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Eusol Biotech Co.,Ltd. (6652). Check the MyAverix Finance app for the latest dividend data.
What sector is Eusol Biotech Co.,Ltd. in?
Eusol Biotech Co.,Ltd. (6652) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 6652 listed on?
6652 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.